Skip to main content

Investors

Ulisse Biomed Group is an integrated biotech group with proprietary technologies, developing diagnostic solutions with a focus on public health, distributed diagnostics and molecular innovation.

About Us

We are technology leaders in distribuited and connected diagnostics


Investors

The Ulysses Biomed Group is an integrated biotech group with proprietary technologies, developing diagnostic solutions with a focus on public health, distributed diagnostics and molecular innovation.


20 September, 2022

Updates and announcements

Hyris to participate in SEI 2022 in Leon, hosted by the Sociedad Española de Immunologia


From September 22nd to September 24th, Hyris will be present at the SEI 2022 in Leon, to show the scientific approach related to our new T Cells test to monitor the cellular immunity to SARS-CoV-2.

On September 22nd at 1pm our Product Specialist Matteo Audano will hold a talk at the dedicated symposium titled "Development of a PCR diagnostic test to monitor the viral cellular immunity".